Sodium-glucose cotransporter type 2 inhibitors and heart failure with preserved ejection fraction: the EMPEROR-Preserved and DELIVER studies

被引：0
作者：
Tomasoni, Daniela
Stretti, Lorenzo
Adamo, Marianna
Metra, Marco
机构：
[1] Univ Brescia, Dipartimento Cardiotorac, UO Cardiol, ASST Spedali Civili Brescia, Brescia, Italy
[2] Univ Brescia, Dipartimento Specialita Med Chirurg Sci Radiol &, Brescia, Italy
来源：
GIORNALE ITALIANO DI CARDIOLOGIA | 2023年 / 24卷 / 04期
关键词：
CARDIOVASCULAR OUTCOMES; EMPAGLIFLOZIN;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：251 / 254
页数：4
相关论文
共 52 条
  • [41] Aiming at harmony. Comparing and contrasting International HFrEF Guidelines
    Tomasoni, Daniela
    Adamo, Marianna
    Bozkurt, Biykem
    Heidenreich, Paul
    McDonagh, Theresa
    Rosano, Giuseppe M. C.
    Virani, Sean A.
    Zieroth, Shelley
    Metra, Marco
    [J]. EUROPEAN HEART JOURNAL SUPPLEMENTS, 2022, 24 : L20 - L28
  • [42] Sodium-glucose co-transporter 2 inhibitors as an early, first-line therapy in patients with heart failure and reduced ejection fraction
    Tomasoni, Daniela
    Fonarow, Gregg C.
    Adamo, Marianna
    Anker, Stefan D.
    Butler, Javed
    Coats, Andrew J. S.
    Filippatos, Gerasimos
    Greene, Stephen J.
    McDonagh, Theresa A.
    Ponikowski, Piotr
    Rosano, Giuseppe
    Seferovic, Petar
    Vaduganathan, Muthiah
    Voors, Adriaan A.
    Metra, Marco
    [J]. EUROPEAN JOURNAL OF HEART FAILURE, 2022, 24 (03) : 431 - 441
  • [43] Sodium-glucose co-transporter 2 inhibition in patients hospitalized for acute decompensated heart failure: rationale for and design of the EMPULSE trial
    Tromp, Jasper
    Ponikowski, Piotr
    Salsali, Afshin
    Angermann, Christiane E.
    Biegus, Jan
    Blatchford, Jon
    Collins, Sean P.
    Ferreira, Joao P.
    Grauer, Claudia
    Kosiborod, Mikhail
    Nassif, Michael E.
    Psotka, Mitchell A.
    Brueckmann, Martina
    Teerlink, John R.
    Voors, Adriaan A.
    [J]. EUROPEAN JOURNAL OF HEART FAILURE, 2021, 23 (05) : 826 - 834
  • [44] Temporal Trends in the Incidence of and Mortality Associated With Heart Failure With Preserved and Reduced Ejection Fraction
    Tsao, Connie W.
    Lyass, Asya
    Enserro, Danielle
    Larson, Martin G.
    Ho, Jennifer E.
    Kizer, Jorge R.
    Gottdiener, John S.
    Psaty, Bruce M.
    Vasan, Ramachandran S.
    [J]. JACC-HEART FAILURE, 2018, 6 (08) : 678 - 685
  • [45] SGLT-2 inhibitors in patients with heart failure: a comprehensive meta-analysis of five randomised controlled trials
    Vaduganathan, Muthiah
    Docherty, Kieran F.
    Claggett, Brian L.
    Jhund, Pardeep S.
    de Boer, Rudolf A.
    Hernandez, Adrian F.
    Inzucchi, Silvio E.
    Kosiborod, Mikhail N.
    Lam, Carolyn S. P.
    Martinez, Felipe
    Shah, Sanjiv J.
    Desai, Akshay S.
    McMurray, John J., V
    Solomon, Scott D.
    [J]. LANCET, 2022, 400 (10354) : 757 - 767
  • [46] Association of epicardial adipose tissue with proteomics, coronary flow reserve, cardiac structure and function, and quality of life in heart failure with preserved ejection fraction: insights from the PROMIS-HFpEF study
    Venkateshvaran, Ashwin
    Faxen, Ulrika Ljung
    Hage, Camilla
    Michaelsson, Erik
    Svedlund, Sara
    Saraste, Antti
    Beussink-Nelson, Lauren
    Fermer, Maria Lagerstrom
    Gan, Li-Ming
    Tromp, Jasper
    Lam, Carolyn S. P.
    Shah, Sanjiv J.
    Lund, Lars H.
    [J]. EUROPEAN JOURNAL OF HEART FAILURE, 2022, 24 (12) : 2251 - 2260
  • [47] Renal effects of empagliflozin in patients hospitalized for acute heart failure: from the EMPULSE trial
    Voors, Adriaan A.
    Damman, Kevin
    Teerlink, John R.
    Angermann, Christiane E.
    Collins, Sean P.
    Kosiborod, Mikhail
    Biegus, Jan
    Ferreira, Joao Pedro
    Nassif, Michael E.
    Psotka, Mitchell A.
    Tromp, Jasper
    Brueckmann, Martina
    Blatchford, Jonathan P.
    Salsali, Afshin
    Ponikowski, Piotr
    [J]. EUROPEAN JOURNAL OF HEART FAILURE, 2022, 24 (10) : 1844 - 1852
  • [48] The SGLT2 inhibitor empagliflozin in patients hospitalized for acute heart failure: a multinational randomized trial
    Voors, Adriaan A.
    Angermann, Christiane E.
    Teerlink, John R.
    Collins, Sean P.
    Kosiborod, Mikhail
    Biegus, Jan
    Ferreira, Joao Pedro
    Nassif, Michael E.
    Psotka, Mitchell A.
    Tromp, Jasper
    Borleffs, C. Jan Willem
    Ma, Changsheng
    Comin-Colet, Joseph
    Fu, Michael
    Janssens, Stefan P.
    Kiss, Robert G.
    Mentz, Robert J.
    Sakata, Yasushi
    Schirmer, Henrik
    Schou, Morten
    Schulze, P. Christian
    Spinarova, Lenka
    Volterrani, Maurizio
    Wranicz, Jerzy K.
    Zeymer, Uwe
    Zieroth, Shelley
    Brueckmann, Martina
    Blatchford, Jonathan P.
    Salsali, Afshin
    Ponikowski, Piotr
    [J]. NATURE MEDICINE, 2022, 28 (03) : 568 - +
  • [49] Side effects and treatment initiation barriers of sodium-glucose cotransporter 2 inhibitors in heart failure: a systematic review and meta-analysis
    Vukadinovic, Davor
    Abdin, Amr
    Anker, Stefan D.
    Rosano, Giuseppe M. C.
    Mahfoud, Felix
    Packer, Milton
    Butler, Javed
    Boehm, Michael
    [J]. EUROPEAN JOURNAL OF HEART FAILURE, 2022, 24 (09) : 1625 - 1632
  • [50] Dapagliflozin in patients with heart failure with mildly reduced and preserved ejection fraction treated with a mineralocorticoid receptor antagonist or sacubitril/valsartan
    Yang, Mingming
    Butt, Jawad H.
    Kondo, Toru
    Jering, Karola S.
    Docherty, Kieran F.
    Jhund, Pardeep S.
    de Boer, Rudolf A.
    Claggett, Brian L.
    Desai, Akshay S.
    Hernandez, Adrian F.
    Inzucchi, Silvio E.
    Kosiborod, Mikhail N.
    Lam, Carolyn S. P.
    Langkilde, Anna Maria
    Martinez, Felipe A.
    Petersson, Magnus
    Shah, Sanjiv J.
    Vaduganathan, Muthiah
    Wilderang, Ulrica
    Solomon, Scott D.
    McMurray, John J., V
    [J]. EUROPEAN JOURNAL OF HEART FAILURE, 2022, 24 (12) : 2307 - 2319
123456